Lung Cancer
News
Crizotinib Boosts Overall Survival of ALK+ Lung Cancer
Major Finding: Selected patients with ALK-positive, advanced NSCLC treated with crizotinib had a 1-year overall survival rate of 74% and a 2-year...
Video
Video Report: Highlights From the World Conference on Lung Cancer
News
International Association Favors CT Screening of Heavy Smokers
News
International Association Favors CT Screening of Heavy Smokers
News
Gene Test Refines Prognosis For Lung Cancer
Major Finding: Adding a commercially available genetic test to standard TNM staging significantly refined the prognosis of stage I and IIa...
News
CT Screening Cuts Lung Cancer Mortality; Raises Policy Questions
Major Finding: Low-dose CT screening reduced the relative rate of death from lung cancer by 20%, compared with chest x-ray screening.Data Source:...
News
FDA Unveils Graphic Cigarette Packaging Intended to Deter Smoking
News
Smoking Bans, Taxes Could Save Nearly $2 Billion in Health Costs
Conference Coverage
European Trial Upholds Use of Erlotinib in EGFR-Mutant Lung Cancer
Major Finding: Erlotinib resulted in a significant 63% reduction in the risk of progression, compared with standard chemotherapy (HR 0.37).Data...
News
European Trial Upholds Use of Erlotinib in EGFR-Mutant Lung Cancer
Major Finding: Erlotinib resulted in a significant 63% reduction in the risk of progression, compared with standard chemotherapy (HR 0.37).Data...
News
Accurate Biomarker Testing Key to Experimental MetMAb in Lung Cancer
Major Finding: Among Met-positive patients, median progression-free survival doubled from 1.5 months with erlotinib to 2.9 months with the...